COPD | WRAL TechWire


Circassia acquires rights to COPD drug, expanding staff

MORRISVILLE -=Circassia Pharmaceuticals, a British company with U.S. headquarters in Morrisville, plans to acquire the full U.S. commercial rights to Tudorza, a treatment for chronic obstructive pulmonary disease (COPD) from British drug-maker AstraZeneca by the end of this month. Circassia, a specialty pharmaceutical company focused on respiratory disease, has...

Read More